Workflow
细胞新药
icon
Search documents
西安:到2027年全市增加仿制药产品16个 化药生物药链群产业规模力争达到120亿元
Mei Ri Jing Ji Xin Wen· 2025-12-17 06:59
每经AI快讯,西安市人民政府办公厅近日印发《促进生物医药产业能力提升实施方案(2025—2027 年)》。其中提出,化药生物药产业链群。通过"仿、创、转",壮大化药生物药产业规模。巩固化学仿 制药产业基础,支持企业加快麻醉、抗生素、心脑血管等领域化学仿制药开发力度,实现"仿创结合", 丰富化学仿制药产品种类。以实现创新药零的突破为牵引,支持企业开展肝靶向药物、多肽药物、干细 胞外泌体药物等创新药研发。充分发挥高校、医疗机构资源优势,加大医药企业与医疗机构的临床研究 合作力度,促进新药尽快落地转化。到2027年,全市增加仿制药产品16个,完成2—3个细胞新药IND申 报工作,化药生物药链群产业规模力争达到120亿元。 ...
为中国式现代化贡献更为强劲的“西安动能”
Xi An Ri Bao· 2025-10-27 06:29
Group 1: Industry Trends and Innovations - The 20th Central Committee's Fourth Plenary Session has sparked a wave of enthusiasm among Xi'an's business community, emphasizing the integration of "high-level socialist market economy" and "new quality productivity" into the economic development plan [1][4] - Xi'an Hengsheng Group is transforming its traditional building materials business into a digital leader, with its "Commercial Concrete Home" platform attracting over 1,000 quality enterprises and serving more than 700 construction projects [1] - The company plans to establish a "Technology Innovation and Enterprise Innovation Integration Development Center" to enhance collaboration between academia and industry, promoting efficient technology transfer and application [1] Group 2: Specific Company Initiatives - Xi'an Aisheng Technology Group, recognized as a "chain leader" in the drone industry, is committed to leveraging technological innovation for high-quality development and aims to capitalize on the emerging low-altitude economy [2] - The company intends to focus on application scenarios to seize opportunities in strategic emerging industries, thereby enhancing its service to the public [2] - Xi'an Jiuzhou Biomedical Technology Group aligns its development philosophy with the emphasis on innovation from the plenary session, focusing on stem cell and immune cell drug research and development [3] - The company is utilizing platforms like the Shaanxi Stem Cell Application Engineering Research Center to advance its cell drug pipeline and bridge the gap between clinical needs and industrialization [3] Group 3: Sustainable Development Goals - Xi'an Taifeng Shenghe Holding Group is focusing on high-end fine chemicals and downstream new materials, aiming to create a sustainable industrial pillar through technological research and financial services [4] - The company expresses confidence in contributing to China's modernization through the development of the private economy, aligning with the goals set forth in the plenary session [4] - The collective innovation efforts of these companies are seen as a driving force for Xi'an's contribution to the "14th Five-Year Plan" and China's modernization [4]